DC-CIK Infusions Restore CD8+Immunity, Physical Activity and Improve Clinical Efficacy in Advanced Cancer Patients
نویسندگان
چکیده
Cancer has become the leading cause of death in the world. According to the data of IARC (Ferlay et al., 2013), there were 14.1 million new cancer cases and 8.2 million cancer deaths in worldwide in 2012. Among them, 21.8% (3.1 million) of new cases and 26.9% (2.2 million) of deaths occurred in China. The ratio of mortality/ incidence in China is higher than the other countries (72% vs 58.2%). These are increasingly demands for more treatment choices for those who failed and/or untolerated to anti-cancer treatments. More and more clinical evidence showed that cancer immunotherapy is becoming one of the promising approaches addressing Eastern Cooperative
منابع مشابه
Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients
PURPOSE To systematically evaluate the efficacy and safety of Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells (CIK/DC-CIK) immunotherapy in treating advanced colorectal cancer (CRC) patients. RESULTS 29 trials including 2,610 CRC patients were evolved. Compared with chemotherapy alone, the combination of chemotherapy with CIK/DC-CIK immunotherapy significantly prol...
متن کاملEffect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment
BACKGROUND Surgical resection combined with adjuvant chemotherapy is considered as the gold-standard treatment for advanced colorectal cancer patients. These patients have a poor 5-year survival rate of 5% or less. Furthermore, a large dose of chemotherapy can produce adverse side effects and severe toxicity. Therefore, this retrospective study aimed to evaluate the efficacy of dendritic cell-c...
متن کاملCytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis
BACKGROUND Immunotherapy based on cytokine-induced killer cells or combination of dendritic cells and cytokine-induced killer cells (CIK/DC-CIK) showed promising clinical outcomes for treating esophageal cancer (EC). However, the clinical benefit varies among previous studies. Therefore, it is necessary to systematically evaluate the curative efficacy and safety of CIK/DC-CIK immunotherapy as a...
متن کاملImmunomodulatory effect of DC/CIK combined with chemotherapy in multiple myeloma and the clinical efficacy.
To investigate the clinical efficacy of adoptive immunotherapy using dendritic cells (DC) and cytokine-induced killer (CIK) cells combined with chemotherapy in multiple myeloma. The immunomodulatory effect of the therapy was discussed by detecting the levels of peripheral blood T cell subsets and CD4(+)CD25(+) regulatory cells (Treg). Fifty MM patients were randomly divided into two groups: 24 ...
متن کاملEfficacy study of CyberKnife stereotactic radiosurgery combined with CIK cell immunotherapy for advanced refractory lung cancer
CyberKnife (CK), hypofractionated stereotactic radiosurgery, is a preferred option for the treatment of advanced refractory lung cancer which is usually inoperable. Cytokine-induced killer (CIK) cell immunotherapy has a marked radiosensitization effect which aids the elimination of residual tumor cells in distant areas. The main purpose of the present study was to evaluate the clinical efficacy...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2015